InvaGen Pharmaceuticals, Inc. recalls
Every recall we track for InvaGen Pharmaceuticals, Inc. — 11 in all, from 2018–2023 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from InvaGen Pharmaceuticals, Inc. peaked in 2018 (5); 11 since 2017. 36% rated “stop using now”.
All FDA recall records for InvaGen Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 2 | 2 | 5 |
| 2019 | 3 | 1 | 0 | 0 | 4 |
| 2020 | 0 | 0 | 1 | 0 | 1 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 1 | 0 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Most common reasons for InvaGen Pharmaceuticals, Inc. recalls
What to do if you have a recalled InvaGen Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All InvaGen Pharmaceuticals, Inc. recalls
8 shown- Lower riskDrug
InvaGen Pharmaceuticals, Inc. recalls Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen
InvaGen Pharmaceuticals recalls Vigabatrin oral solution due to risk of powder leaking from pouches. This medication is prescription-only and may cause ineffective treatment if powder leaks.
InvaGenNov 17, 2023 - Lower riskDrug
InvaGen Pharmaceuticals, Inc. recalls Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc.,
InvaGen Pharmaceuticals recalls 600mg Gabapentin tablets due to impurity failure in long-term stability testing. Affected lots may pose risks if stored beyond expiration.
InvaGenMay 14, 2020 - Use cautionDrug
InvaGen Pharmaceuticals, Inc. recalls Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution
InvaGen recalls Testosterone Topical Solution due to defective containers that may deliver incorrect doses. Check lot numbers GH80480 and GH80481.
InvaGen PharmaceuticalsJun 12, 2019 - Stop using nowDrug
InvaGen Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial,
InvaGen Pharmaceuticals recalls testosterone cypionate injections with particulate matter. Affected lots manufactured in India and shipped to US. Stop using immediately if you have the recalled product.
InvaGen PharmaceuticalsMar 22, 2019 - Lower riskDrug
InvaGen Pharmaceuticals, Inc. recalls Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India,
InvaGen Pharmaceuticals recalls 10 mg Amlodipine Besylate tablets due to subpotent drug quality. This means the medication may not be as effective as labeled, potentially requiring higher doses for treatment.
InvaGen PharmaceuticalsOct 3, 2018 - Stop using nowDrug
InvaGen Pharmaceuticals, Inc. recalls Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for:
InvaGen Pharmaceuticals recalls 150mg Bupropion ER tablets with impurities from batches older than 18 months. These tablets may contain harmful levels of meta-chlorobenzoic acid, posing a risk of serious injury if taken.
InvaGenSep 6, 2018 - Lower riskDrug
InvaGen Pharmaceuticals, Inc. recalls buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC
InvaGen Pharmaceuticals recalls 150mg buPROPion HCl Extended-Release Tablets due to failed dissolution testing during stability checks. These prescription pills (NDC 69097-878-03 and 69097-878-07) may not release medication properly.
InvaGenMar 15, 2018 - UnratedDrug
InvaGen Pharmaceuticals, Inc. recalls Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for:
InvaGen Pharmaceuticals recalls Decitabine injection (50mg/vial) due to impurities and water content issues. This medication, prescribed only, may pose risks if used improperly. Affected lots from India manufacturer.
InvaGen PharmaceuticalsMar 5, 2018
InvaGen Pharmaceuticals, Inc. recall questions
How many recalls has InvaGen Pharmaceuticals, Inc. had?
11 recalls from InvaGen Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2018–2023.
What is the most recent InvaGen Pharmaceuticals, Inc. recall?
InvaGen Pharmaceuticals, Inc. recalls Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen, dated Nov 17, 2023. Every InvaGen Pharmaceuticals, Inc. recall is listed on this page, newest first.
Why are InvaGen Pharmaceuticals, Inc. products recalled?
The most common reasons on record: Presence of Particulate Matter. (3); Failed Dissolution Specifications; during stability testing (2).
What should I do if I have a recalled InvaGen Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new InvaGen Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.